{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "12645335",
  "DateCompleted": {
    "Year": "2003",
    "Month": "04",
    "Day": "02"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "05",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0002-9173",
      "JournalIssue": {
        "Volume": "119",
        "Issue": "3",
        "PubDate": {
          "Year": "2003",
          "Month": "Mar"
        }
      },
      "Title": "American journal of clinical pathology",
      "ISOAbbreviation": "Am J Clin Pathol"
    },
    "ArticleTitle": "Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer.",
    "Pagination": {
      "StartPage": "346",
      "EndPage": "355",
      "MedlinePgn": "346-55"
    },
    "Abstract": {
      "AbstractText": [
        "To study KLK14 gene expression in endocrine-related cancers, we studied its hormonal regulation in breast and ovarian cancer cell lines. Our kinetic and blocking experiments suggest that this up-regulation is mediated through the androgen receptor. We then studied the expression of KLK14 by quantitative reverse transcriptase-polymerase chain reaction in 155 consecutive ovarian tumors and correlated these findings with clinicopathologic parameters, response to chemotherapy, and survival. A stepwise reduction was observed in the levels of KLK14 messenger RNA in normal, benign, and cancerous tissues (P < .001). Expression levels were significantly higher in patients with early stage disease and optimal debulking and in patients who responded to chemotherapy. Kaplan-Meier survival curves demonstrated longer progression-free and overall survival in patients with KLK14-positive tumors than in patients with KLK14-negative tumors (P < .001). When all other prognostic variables were controlled in the multivariate analysis, KLK14 retained its prognostic significance (progression-free and overall survival, respectively, hazard ratios, 0.43 and 0.53; P = .027 and .014). A weak negative correlation was found between KLK14 expression and serum CA-125. KLK14 is a new, independent, and favorable prognostic marker for ovarian cancer."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dept of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Ave, Toronto, Ontario, Canada M5G 1X5."
          }
        ],
        "LastName": "Yousef",
        "ForeName": "George M",
        "Initials": "GM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Fracchioli",
        "ForeName": "Stefano",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Scorilas",
        "ForeName": "Andreas",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Borgo\u00f1o",
        "ForeName": "Carla A",
        "Initials": "CA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Iskander",
        "ForeName": "Lisa",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Puopolo",
        "ForeName": "Manuela",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Massobrio",
        "ForeName": "Marco",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Diamandis",
        "ForeName": "Eleftherios P",
        "Initials": "EP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Katsaros",
        "ForeName": "Dionyssios",
        "Initials": "D"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Am J Clin Pathol",
    "NlmUniqueID": "0370470",
    "ISSNLinking": "0002-9173"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Biomarkers, Tumor"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Messenger"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Neoplasm"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, Androgen"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Steroids"
    },
    {
      "RegistryNumber": "EC 3.4.21.-",
      "NameOfSubstance": "KLK14 protein, human"
    },
    {
      "RegistryNumber": "EC 3.4.21.-",
      "NameOfSubstance": "Kallikreins"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Biomarkers, Tumor"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Breast Neoplasms"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Carcinoma"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease-Free Survival"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Gene Expression Regulation, Neoplastic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Kallikreins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Ovarian Neoplasms"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "RNA, Messenger"
    },
    {
      "QualifierName": [
        "analysis"
      ],
      "DescriptorName": "RNA, Neoplasm"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Receptors, Androgen"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Reverse Transcriptase Polymerase Chain Reaction"
    },
    {
      "QualifierName": [
        "metabolism",
        "pharmacology"
      ],
      "DescriptorName": "Steroids"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Tumor Cells, Cultured"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Up-Regulation"
    }
  ]
}